From the early clinical trials involving chimeric antigen receptor T cell therapy (CAR-T), cytokine release syndrome has been a major problem. To block the high levels of interleukin 6, what has been used in clinical trials?
A. Etanercept
B. Infliximab
C. Methotrexate
D. Adalimumab
